RGS1 serves as an anti-tumor target to inhibit proliferation of NICN87-DR cells and tumor growth in gastric cancer mouse model

Authors

ZHIXIONG CHEN
BANGLUN LIU
SHOURU ZHANG
LIHUI CHEN
YUYU LV
HAO SUN

Abstract

Gastric cancer is becoming the 4th leading cause of cancer-associated death worldwide. The purpose of this study was to investigate the role of RGS1 in gastric cancer in vitro and in vivo. Proliferation, migration, invasion, and colony formation of NCIN87 cells and drug-resistant NCIN87 cells (NCIN87-DR) were determined. Cell apoptosis and cell cycle were examined using a flow cytometry assay. RGS1 gene knock-down vector (pLVshshRGS1) and Xenograft tumor mouse model was generated. RGS1 and epithelial-mesenchymal transition (EMT) associated markers, including E-cadherin (E-cad), N-cadherin (N-cad), Slug, and Vimentin were detected using a western blotting assay. Tumor size of Xenograft tumor mouse was measured and Ki67 expression was detected using the immunohistochemical assay. NCIN87-DR cells demonstrated significantly lower proliferation, migration, and invasion compared to those of NCIN87 cells (p < 0.05). NCIN87-DR cells showed obvious early apoptosis and displayed obvious alterations for the cell cycle. NCIN87-DR cells exhibited predominantly higher RGS1 expression than that in NCIN87 cells (p < 0.01). E-cad expression was markedly decreased (p < 0.01) and N-cad (p < 0.05), Slug (p < 0.01), Vimentin (p < 0.05) expressions were significantly increased in NCIN87-DR cells than those in NCIN87 cells. RGS1 gene silence remarkably reduced NCIN87-DR proliferation compared to that in NCIN87-DR cells without treatment (p < 0.01). RGS1 gene-silenced NCIN87-DR cell immunization predominantly inhibited tumor growth in Xenograft tumor mouse than that without RGS1 silence (p < 0.05). RGS1 gene-silenced NCIN87-DR cell immunization significantly downregulated Ki67 expression in tumor tissues compared with that without RGS1 silence. In conclusion, RGS1 gene silence reduced the proliferation of NCIN87-DR cells in vitro and inhibited tumor growth in vivo. Therefore, RGS1 served as an antitumor target for the gastric cancer treatment.

DOI

10.55730/1300-0152.2616

Keywords

RGS1, gastric cancer, drug-resistance, proliferation, treatment

First Page

277

Last Page

287

Recommended Citation

CHEN, ZHIXIONG; LIU, BANGLUN; ZHANG, SHOURU; CHEN, LIHUI; LV, YUYU; and SUN, HAO (2022) "RGS1 serves as an anti-tumor target to inhibit proliferation of NICN87-DR cells and tumor growth in gastric cancer mouse model," Turkish Journal of Biology: Vol. 46: No. 4, Article 2. https://doi.org/10.55730/1300-0152.2616
Available at: https://journals.tubitak.gov.tr/biology/vol46/iss4/2